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ORIGINAL ARTICLE
Heterogeneity in Conduction Underlies Obesity-
Related Atrial Fibrillation Vulnerability
Corina Schram-Serban, DVM; Annejet Heida, MD; Maarten C. Roos-Serote, PhD; Paul Knops, BSc; Charles Kik, MD;  
Bianca Brundel , PhD; Ad J.J.C. Bogers, MD, PhD; Natasja M.S. de Groot , MD, PhD
BACKGROUND: Obese patients are more vulnerable to development of atrial fibrillation but pathophysiology underlying this 
relation is only partly understood. The aim of this study is to compare the severity and extensiveness of conduction disorders 
between obese patients and nonobese patients measured at a high-resolution scale.
METHODS: Patients (N=212) undergoing cardiac surgery (male:161, 63±11 years) underwent epicardial mapping of the 
right atrium, Bachmann bundle, and left atrium during sinus rhythm. Conduction delay (CD) was defined as interelectrode 
conduction time of 7 to 11 ms and conduction block (CB) as conduction time ≥12 ms. Prevalence of CD/CB, continuous 
CDCB (cCDCB), length of CD/CB/cCDCB lines, and severity of CB were analyzed.
RESULTS: In obese patients, the overall incidence of CD (3.1% versus 2.6%; P=0.002), CB (1.8% versus 1.2%; P<0.001), and 
cCDCB (2.6% versus 1.9%; P<0.001) was higher and CD (P=0.012) and cCDCB (P<0.001) lines are longer. There were 
more conduction disorders at Bachmann bundle and this area has a higher incidence of CD (4.4% versus 3.3%, P=0.002), 
CB (3.1% versus 1.6%, P<0.001), cCDCB (4.6% versus 2.7%, P<0.001) and longer CD (P<0.001) or cCDCB (P=0.017) 
lines. The severity of CB is also higher, particularly in the Bachmann bundle (P=0.008) and pulmonary vein (P=0.020) areas. 
In addition, obese patients have a higher incidence of early de-novo postoperative atrial fibrillation (P=0.003). Body mass 
index (P=0.037) and the overall amount of CB (P=0.012) were independent predictors for incidence of early postoperative 
atrial fibrillation.
CONCLUSIONS: Compared with nonobese patients, obese patients have higher incidences of conduction disorders, which are 
also more extensive and more severe. These differences in heterogeneity in conduction are already present during sinus 
rhythm and may explain the higher vulnerability to atrial fibrillation of obese patients.
VISUAL OVERVIEW: A visual overview is available for this article.
Key Words: atrial fibrillation ◼ body mass index ◼ cardiac electrophysiology ◼ incidence ◼ obesity
Obesity is a rampant epidemic and a well-established, highly prevalent risk factor for atrial fibrillation (AF).1 The mechanisms by which obesity contributes to AF 
development include associated risk factors (eg, diabe-
tes mellitus, hypertension, hyperlipidemia, and coronary 
artery disease) and atrial substrate modifiers2 (eg, epi-
cardial fat infiltrations, atrial fibrosis, and enhanced local 
inflammation because of increased adipocytokines and 
proinflammatory cytokines).
Previous human and experimental studies have 
reported on the relationship between the presence of 
epicardial adipose tissue and atrial electropathology.3–6 
In a 26 patients study group, Mahajan et al observed 
global reduction in conduction velocity in obese patients 
examined by endocardial electroanatomic mapping dur-
ing sinus rhythm (SR). In the ovine experimental model 
of chronic obesity, endocardial electroanatomic map-
ping showed slowed and heterogenous conduction, an 
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increased incidence of complex fractionated electro-
grams (e-grams) and an increased voltage heterogene-
ity with reduction of voltages in the posterior left atrial 
wall.4 In progressive weight gain ovine models,5 conduc-
tion velocities and conduction heterogeneity indices 
assessed during pacing cycle at different cycle lengths 
from 4 directions5 revealed that increasing adiposity was 
associated with the extent of conduction slowing and 
conduction heterogeneity.5
As data on atrial conduction properties in obese 
humans is scarce,3 the aim of this study is to compare 
the severity and extensiveness of conduction disorders in 
both atria between obese patients and matched nonobese 
patients measured at high resolution scale during SR.
METHODS
The data that support the findings of this study are available 
from the corresponding author upon reasonable request.
Study Population
The study population consisted of adult patients sched-
uled for elective cardiac surgery for coronary artery disease, 
either isolated or in combination with aortic (coronary artery 
disease+aortic valve disease) or mitral (coronary artery 
disease+mitral valve disease) valve disease, isolated aortic 
(aortic valve disease) or mitral valve disease or correction of 
congenital heart defects. Patients with congenital heart defects 
disease included atrial septal defects (70%), partial anoma-
lous pulmonary venous return (11%), ventricular septal defects 
(5%), total anomalous pulmonary venous return (5%), and 
transposition of the great vessels (5%).
Exclusion criteria were history of AF, prior ablation of atrial 
tachyarrhythmias, severe renal failure, atrial pacing and patients 
requiring mechanical or inotropic support. The population was 
divided into 2 categories: (1) obese patients (body mass index 
[BMI] ≥30) and (2) nonobese patients (BMI<30).
This study was conducted as part of 2 prospective observa-
tional projects including Quest for Arrhythmogenic Substrate of 
Atrial fibrRillation (QUASAR, MEC 2010-054) and Hsf1 acti-
vators lower cardiomyocyte damage toward a novel approach 
to REVERSE atrial fibrillation (HALT & REVERSE, MEC 
2014-393). Both projects were approved by the local ethics 
committee of the Erasmus Medical Centre and adhere to the 
Declaration of Helsinki principles. Accordingly, written consent 
was obtained from the participating patients before surgical 
intervention.
Epicardial High-Resolution Mapping
Epicardial high-resolution mapping was performed during open 
chest cardiac surgery after sternotomy and before connect-
ing the patient to the cardiopulmonary bypass circulation.6,7 
A bipolar pacemaker wire was placed at the right atrial free 
wall to serve as a temporal reference electrode. The indifferent 
electrode was a steel wire attached to thoracic subcutaneous 
tissue.6 The mapping procedure was performed using 16 mm 
width electrode arrays containing either 128 or 192 unipolar 
electrodes (2.0-mm interelectrode distance) with diameters of 
0.65 and 0.45 mm, respectively.7
Epicardial mapping during SR was conducted following a 
predefined mapping scheme as shown in Figure I in the Data 
Supplement (left upper panel), approaching the entire epicar-
dial surface of the right atrium (RA), Bachmann Bundle (BB), 
and LA.6 As previously described,6–8 the electrode array was 
shifted along the imaginary lines with a fixed orientation at each 
position. Mapping of the RA started at the cavo-tricuspid isth-
mus and continued perpendicular to the caval veins toward the 
RA appendage. BB was mapped starting at the tip of the LA 
appendage across the roof of the LA, behind the aorta toward 
the superior cavo-atrial junction.7 Mapping of the LA was per-
formed from the lower margin of the left inferior pulmonary 
vein (PV) along the left atrioventricular groove towards the LA 
appendage.6 The PV area was mapped from the sinus trans-
versus fold, in between the right and left PV toward the left 
atrioventricular groove.7
From every atrial mapping site, 5 seconds of SR were 
recorded, including surface ECG (lead I), a bipolar reference 
electrogram, a calibration signal with an amplitude of 2 mV 
and 1000 ms and unipolar epicardial electrograms. Recordings 
were sampled with a rate of 1 kHz, amplified (gain:1000), 
Nonstandard Abbreviations and Acronyms
AF atrial fibrillation
BB Bachmann Bundle
BMI body mass index
CD conduction delay
CB conduction block
cCDCB  continuous conduction delay conduc-
tion block
EPoAF early postoperative atrial fibrillation
OR odds ratio
PV pulmonary vein
RA right atria
SR sinus rhythm
WHAT IS KNOWN?
• Obesity is a rampant epidemic and a well-estab-
lished, highly prevalent risk factor for atrial fibrillation.
• Endocardial electroanatomic mapping of limited 
atrial regions showed that obesity is associated with 
slowed and heterogenous conduction and global 
reduction in conduction velocity during sinus rhythm.
WHAT THE STUDY ADDS?
• High-resolution epicardial mapping of the entire atrial 
surface shows that obese patients have an overall 
higher incidence and severity of conduction abnor-
malities, particularly in the Bachmann Bundle area.
• In addition, obese patients have a higher incidence 
of early de-novo postoperative atrial fibrillation, body 
mass index, and the overall amount of conduction 
block being independent predictors for incidence 
of early postoperative atrial fibrillation.
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filtered (bandwidth: 0.5–400 Hz), converted from analog to 
digital (16 bits) and stored on a hard disk.
Analysis of Mapping Data
Figure I in the Data Supplement shows all mapping locations, 
including BB, RA1-4, LA1-2, PVR, and PVL on a schematic 
posterior view of the atrial surface. Colour-coded local acti-
vation maps during SR were constructed by annotating the 
steepest negative deflection of atrial electrograms with a min-
imum slope threshold of 0.05 mV/ms. The ratio of threshold 
amplitude to noise amplitude was set at 2. Atrial extrasystolic 
beats were excluded.
Differences in local activation times (local conduction 
delay) were calculated between neighbouring electrodes 
(adjacent right and lower) resulting in 2 conduction delays 
per electrode (Figure I in the Data Supplement left lower). As 
previously described, conduction delay (CD) and conduction 
block (CB) were defined as differences in local activation time 
(∆CT) between adjacent electrodes of 7 to 11 and ≥12 ms, 
respectively.9–12 This finding corresponds to effective conduc-
tion velocities of 17 to 29 cm/s for CD and <17 cm/s for CB, 
respectively. Lines of CD, CB, and continuous CDCB (cCDCB) 
were defined as uninterrupted series of, respectively, inter-
electrode CD, CB, or a combination of CD and CB. Lengths of 
these lines were measured and analyzed as the median length 
of lines per patient as well as length of the longest line per 
patient. Incidence of CD and CB are expressed as a percent-
age of the total available number of interelectrode connections. 
Therefore, the percentage of CD/CB per mapping location was 
calculated using the following formulas6:
%CD = 
Number of CT  7 ms
Total number of CT
and %CB = 
Number≥  of CT  12 ms
Total number of CT
≥
Difference in severity of CB between obese and nonobese 
patients was investigated by calculating median CTs derived 
from all values for conduction time ≥12 ms per electrode in 
every patient separately.
Early De-Novo Postoperative AF
Early de-novo postoperative (EPoAF) was defined as the inci-
dence of at least one AF episode with a duration of minimum 
30 seconds during the first 5 postoperative days. EPoAF was 
confirmed by ECG, continuous rhythm monitoring, or patient 
discharge letters and clinical notes.
Statistical Analysis
Statistical analysis was performed using the IBM SPSS 
Statistics 24 software (Corp, Armonk, NY software). Propensity 
score matching analysis was performed using logistic regres-
sion, cases being randomly assigned to controls based on 
the nearest neighboring propensity score (match tolerance 
0.05). Data were tested using Shapiro-Wilk test of normal-
ity. Continuous, normally distributed data are expressed as 
mean±SD and skewed data as median and range (minimum-
maximum). Student T-test was used to compare normally dis-
tributed continuous variables, while skewed parameters were 
compared using Mann-Whitney U test. Comparisons between 
related skewed variables were performed using Wilcoxon test. 
Categorical variables were compared using χ2 test and are 
presented as percentages. Bonferroni correction was used 
for multiple comparisons. Pearson correlation test was used 
to evaluate the linear relationship between variables. Possible 
predictors for EPoAF were manually entered in a multivariate 
binary logistic regression based on P value (≤0.15) in univariate 
analysis or clinical relevance. A 2-sided P-value of <0.05 was 
considered statistically significant.
RESULTS
Study Population
Baseline characteristics of both the obese (N=106, 
64±10 years; 78 (74%) male) and nonobese group 
(N=106, 62±12; 83 [78%] male) are presented in 
Table 1. Clinical characteristics between the obese 
and nonobese group only differed in BMI (32.9±2.9 
versus 25.4±2.4). Coronary artery bypass grafting 
was the main surgical procedure performed in both 
groups (obese patients: 70 [66%] and nonobese 
patients: 64 [60%]).
Mapping Data
The total number of recording sites (electrodes) in 
the obese group was 202 304 (1909±320.6 elec-
trodes/patient) and 200 192 in the nonobese group 
(1889±310.7 electrodes/patient, P=0.411). After 
exclusion of 0.65% of mapping sites due to poor signal-
to-noise ratios, respectively, 1333 (12.5±4.2 per patient) 
and 1321 (12.4±4.1 per patient) mapping locations 
were available for further analysis (P=0.617).
Heterogeneity in Conduction
Areas of CD and CB were present in all patients. Fig-
ure 1 depicts examples of CD/CB maps obtained from 
a typical obese and nonobese patient constructed from 
respectively RA, BB, LA, and PV. These maps clearly 
show that there are not only more CD or CB lines in 
the obese patient, but that these CD/CB lines are also 
longer. The upper panel of Figure 2 shows that obe-
sity is indeed associated with higher incidences (3.1% 
[0.0–20.4] versus 2.6% [0.0–10.9], P=0.002) and lon-
ger lengths (3.3 mm [2.0–12.0] versus 3.0 mm [2.0–9.0], 
P=0.012) of CD lines.
The middle panel of Figure 2 shows that though the 
length of CB lines were similar between obese (5 mm 
[2.0–42.0]) and nonobese patients (4.8 mm [2.0–26.0]), 
(P=0.059), there was a higher incidence of CB lines 
(1.8% [0.0–25.1] versus 1.2% [0.0–12.6]), P<0.001 in 
the obese group. In addition, the incidence of cCDCB 
was also higher in obese (2.6% [0.0–39.8] compared 
with nonobese patients (1.9% [0.0–17.9], P<0.001) as 
shown in the lower panel of Figure 2. Again, these lines 
were also longer (14 mm [4.0–83]) versus 13.6 mm 
[4.0–116.0], P<0.001).
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Predilection Sites for Conduction Abnormalities
Regional differences in incidences of CD, CB, and 
cCDCB lines for the obese and nonobese groups sep-
arately are demonstrated in Figure 3 and summarized 
in Table 2. In both groups, conduction abnormalities 
were observed at all atrial sites but preferentially at 
BB. The upper panel of Figure 3 shows that the inci-
dence of CD lines at BB was significantly higher in the 
obese group (4.4% [0.3–20.4] versus 3.3% [0.0–10.9], 
P=0.002) and these lines were also longer (4.0 mm 
[2.0–8.0] versus 3.0 mm [2.0–9.0], P<0.001). In the LA 
area, obese patients also had a higher incidence of CD 
lines (2.5% [0.0-9.1] versus 2.0% [0.0–8.6], P=0.047), 
but the length of CD lines was not different between 
the 2 groups.
Predilection sites for CB lines are depicted in the 
middle panel of Figure 3. Though the lengths of CB 
lines were similar between obese and nonobese patients 
within all atrial areas, obese patients had significantly 
higher incidences of CB lines at BB (3.1% [0.0–25.1] 
versus 1.6% [0.0–12.6], P<0.001) and RA (2.6% [0.0–
18.1] versus 2.0% [0.0–11.7], P=0.049). Furthermore, 
as shown in the lower panel of Figure 3, incidences of 
cCDCB lines (4.6% [0.0–39.8] versus 2.7% [0.0–17.9], 
P<0.001) at BB were higher and lengths of these lines 
were longer (16.0 mm [6.0–83.0] versus 14.0 mm [6.0–
116.0] P=0.017) in the obese patients.
Heterogeneity in Conduction in Coronary Artery 
Bypass Grafting Patients
Areas of CD and CB were present in all coronary artery 
bypass grafting patients. Higher incidence of CD was 
observed in obese (3.2% [0.0–20.4]) compared with 
nonobese patients (2.6% [0.0–9.4], P=0.003) along 
with longer lines of CD (obese 3.5 mm [2.0–12.0] ver-
sus nonobese 3.0 mm [2.0–9.0]; P=0.003). There was 
also an increase in CB incidence in obese (1.6% [0.0–
25.1]) versus nonobese patients (1.1% [0.0–12.6], 
P=0.003). Significantly higher incidences of CD were 
observed in obese patients at BB (3.3% [0.0–20.4] 
versus 2.2% [0.0–9.4]; P<0.001) and LA (3.3% [0.4–
11.0] versus 2.5% [0.1–6.4]; P=0.012), with longer CD 
lines at LA (4.0 mm [2.0–9.0] versus 3.2 mm [2.0–8.0]; 
P=0.013). Obese patients also had higher incidences 
of CB at BB (1.6% [0.0–25.1] versus 1.0% [0.0–7.2]; 
P=0.006) and LA (1.7% [0.0–16.0] versus 1.1% [0.0–
8.1]; P=0.020).
Severity of Conduction Block
Figure 4 depicts differences in severity of CB (∆CT ≥12 
ms) between obese and nonobese patients. The upper 
panel shows that within the entire atria, CB with severi-
ties ≥15 ms occurs more frequently in obese patients 
with (P=0.001). In the lower panels, differences in sever-
ity of CB is shown for obese and nonobese patients for 
each of the 4 mapping locations separately; CB was 
significantly more severe in the obese patients at BB 
(P=0.008) and PV (P=0.020).
Incidence and Risk Factors for Early De-Novo 
PoAF
Figure II in the Data Supplement shows that the inci-
dence of EPoAF was higher in the obese group (36% 
[N=38] versus 17% [N=18]; P=0.003). Univariate and 
multivariate predictors for EPoAF Table 3 with their 
respective odds ratio (OR) values and 95% CIs. Sig-
nificant univariate predictive factors for incidence of 
EPoAF include HT (OR, 1.332; P=0.004), LAE (OR, 
Table 1. Patient Characteristics
Obese  
Patients
Nonobese 
Patients
P Value
BMI ≥30 
(N=106)
BMI <30 
(N=106)
Age, y 63.5±9.6 62.3±11.8 0.742
Male sex, N (%) 78 (74) 83 (78) 0.521
BMI 32.9±2.9 25.4± 2.4 <0.001
Risk factors, N (%)
 Hypertension 65 (61.3) 60 (56.6) 0.577
 Diabetes mellitus 37 (35) 25 (23.5) 0.096
 Dyslipidemia 44 (41.5) 42 (39.6) 0.889
Left ventricular function 0.357
 Normal (EF >55%) 84 (79.2) 83 (78.3)  
 Mild impairment (EF 
46%–55%)
21 (19.8) 18 (17)  
 Moderate impairment 
(EF 36%–45%)
1 (0.9) 3 (2.8)  
 Severe impairment (EF 
<35%)
0 (0) 2 (1.9)  
Left atrial dilatation, N (%; 
LA diameter, ≥45 mm)
15 (14.1) 16 (15) 0.679
Preoperative medication, N (%)
 Antiarrhythmic drugs
  Class II 46 (68.6) 59 (66.2) 0.863
  Class IV 2 (3) 4 (4.4) 0.467
 ACE inhibitors 42 (62.6) 49 (55) 0.412
Surgical procedure, N (%) 0.277
 CABG 70 (66) 64 (60.3)  
 AVD 10 (9.4) 12 (11.3)  
 MVD 2 (1.8) 7 (6.6)  
 CABG+AVD 15 (14.1) 11 (10.3)  
 CABG+MVD 3 (2.8) 1 (0.9)  
 CHD 6 (5.6) 11 (10.3)  
Statistically significant values (P<0.05). ACE indicates angiotensin-converting 
enzyme; AVD, aortic valve disease; BMI, body mass index; CABG, coronary artery 
bypass grafting; CHD, congenital heart disease; EF, ejection fraction; and MVD, 
mitral valve disease.
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Figure 1. Examples of colour-coded activation maps show the distribution of lines conduction delay (CD; blue) and conduction 
block (CB; red) within predefined atrial areas from an obese patient (left) and a nonobese matched control patient (right).
These maps show that there is an increase in both incidence and length of lines of CD and CB in the obese patient. The incidence 
of conduction abnormalities are expressed as percentage of CD and CB for every region separately. BB indicates Bachmann 
Bundle; CB, conduction block; CD, conduction delay; LA, left atria, LAT, local activation time; PV, pulmonary vein area; Pt, patient; 
and RA, right atria.
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1.908; P=0.008), BMI (1.084; P<0.001), mitral valve 
disease (OR, 3.013; P=0.039), and coronary artery 
bypass grafting (OR, 9.159; P<0.001). Though none of 
the electrophysiological parameters showed any signifi-
cant association with incidence of EPoAF in the univari-
ate analysis, the multivariate model showed a significant 
relation between incidence of CB (OR, 1.307; P=0.012) 
and EPoAF. Other significant associations between clini-
cal parameters and incidence of EPoAF include HL (OR, 
2.921; P<0.001), LAE (OR, 2.302; P=0.008), and BMI 
(OR, 1.064; P=0.037).
DISCUSSIONS
Key Findings
This study compared the incidence, extensiveness, and 
severity of areas of CD and/or CB at the atrial epicardial 
Figure 2. Graphs demonstrating the median and ranges (minimum-maximum) of the incidence (%) and length of conduction 
delay (CD), conduction block (CB), and continuous conduction delay conduction block (cCDCB) lines within the entire atria.
Upper: there was not only a significant increase in the amount of CD in obese patients (P=0.002), but these CD lines of CD were also longer 
(P=0.012). The middle: obese patients had a significantly higher incidence of CB within the entire atria (P<0.001). Lower: both incidence and 
lines of continuous CDCB were significantly higher in obese compared with nonobese patients (P<0.001).
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surface during SR between obese and nonobese patients 
without previous history of AF measured at high reso-
lution scale. In obese patients, the overall incidence of 
CD, CB, and cCDCB is higher and CD and cCDCB lines 
are longer. There are more conduction disorders at BB 
and this area has higher incidences of CD, CB, cCDCB 
and longer CD or cCDCB lines. The severity of CB is 
also higher, particularly in the BB and PV areas. In addi-
tion, obese patients have a higher incidence of early de-
novo postoperative atrial fibrillation. BMI and the overall 
amount of CB were independent predictors for incidence 
of early postoperative atrial fibrillation.
Figure 3. Distribution of incidences and lengths of conduction delay (CD), conduction block (CB), and continuous 
conduction delay conduction block (cCDCB) lines within predefined atrial mapping sites presented on a schematic 
posterior view of the atria.
The areas that are significantly different between obese and nonobese patients are highlighted in red. The upper shows that BB was a 
predilection site of higher incidences (P=0.002) and longer lines of CD (P<0.001) in obese patients. In these patients, the amount of CD was 
also significantly higher in the LA region (P=0.047). The middle panel demonstrates that the incidence of CB was significantly higher in obese 
compared with nonobese patients at Bachmann Bundle (BB; P<0.001) and right atria, respectively (P=0.049). The lower panel shows that BB 
is the only area with a higher incidence (P<0.001) and longer lines (P=0.017) of cCDCB in obese compared with nonobese patients.
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Obesity and Conduction Abnormalities
Previous studies have shown the epidemiological link 
between obesity and AF; however, the underlying elec-
trophysiological characteristics and mechanisms are 
yet to be defined.13–15 BMI, as a measure of systemic 
adiposity is associated with an increase in the amount 
of pericardial and epicardial fat.16,17 Through its para-
crine effect, epicardial adipose tissue contributes to the 
development of atrial interstitial fibrosis.18 Infiltration of 
myocardium with adipocytes along with fibrosis results 
in heterogenous atrial conduction caused by increased 
nonuniform anisotropy, which contributes to endo and 
epicardial electrical dissociation.19–21 This process in turn 
favors development of atrial reentry and hence AF.18
Our study shows that the incidence and extent of 
atrial conduction abnormalities were significantly higher 
in obese compared with nonobese patients. Similar find-
ings were presented by Magnani et al in a cross-sec-
tional analysis to determine the association of obesity 
with P wave indices. Multivariable analysis of resting 
12-lead ECG recordings showed significant progressive 
increases in PR interval, P wave maximum duration, and 
P wave terminal force in overweight and obese patients 
compared with the reference group.22 All these find-
ings support the involvement of obesity in evolvement of 
atrial electropathology including conduction abnormali-
ties. Moreover, our study shows that BB was a predilec-
tion site for conduction disorders. BB, the preferential 
inter-atrial connection ensures bi-atrial synchronous 
contraction.23 Depositions of epicardial adipose tissue 
in this region stimulates development of atrial interstitial 
fibrosis and therefore contribute to interatrial conduc-
tion abnormalities and subsequently promote the risk 
for arrhythmogenesis.24 Though obesity was associated 
with a statistical higher incidence and extent of conduc-
tion abnormalities, the magnitude of differences between 
obese and nonobese patients remains relatively small. 
These findings may therefore be related to the large 
sample used in the comparison.
Table 2. Conduction Parameters Within Predefined Atrial Areas
Region Conduction Parameter Obese Patients Nonobese Patients P Value
BB CD (%) 4.4 (0.3–20.4) 3.3 (0.0–10.9) 0.002
 CB (%) 3.1 (0.0–25.1) 1.6 (0.0–12.6) <0.001
cCDCB (%) 4.6 (0.0–39.8) 2.7 (0.0–17.9) <0.001
Length of CD lines, mm 4.0 (2.0–8.0) 3.0 (2.0–9.0) <0.001
Length of CB lines, mm 5.5 (2.0–23.0) 4.0 (2.0–23.0) 0.190
Length of cCDCB lines, mm 16.0 (6.0–83.0) 14.0 (6.0–116.0) 0.017
∆CT, ms 15.1 (12.0–43.0) 14.2 (12.0–39.0) 0.008
RA CD (%) 3.3 (0.5–13.0) 3.1 (0.3–10.2) 0.422
 CB (%) 2.6 (0.0–18.1) 2.0 (0.0–11.7) 0.049
Continuous cCDCB (%) 3.1 (0.0–23.7) 2.7 (0.0–15.4) 0.088
Length of CD lines, mm 2.8 (2.0–5.3) 2.6 (2.0–5.1) 0.543
Length of CB lines, mm 5.5 (2.0–19.6) 5.3 (2.0–22.5) 0.453
Length of cCDCB lines, mm 14.7 (5.3–42.7) 14.3 (4.0–47.2) 0.309
∆CT, ms 17.9 (12.3–43.0) 17.0 (12.0–42.0) 0.070
LA CD (%) 2.5 (0.0–9.1) 2.0 (0.0–8.6) 0.047
 CB (%) 0.9 (0.0–15.2) 0.7 (0.0–5.7) 0.186
cCDCB (%) 1.6 (0.0–9.8) 0.9 (0.0–6.5) 0.211
Length of CD lines, mm 4.0 (2.0–9.0) 4.0 (2.0–8.2) 0.666
Length of CB lines, mm 5.0 (2.0–24.7) 4.7 (2.0–26.0) 0.763
Length of cCDCB lines, mm 13.0 (4.0–36.2) 12.7 (5.0–46.0) 0.757
∆CT, ms 14.7 (12.0–45.0) 14.1 (12.0–38.0) 0.650
PV CD (%) 2.6 (0.0–11.0) 2.3 (0.0–10.7) 0.554
 CB (%) 1 (0.0–13.2) 0.7 (0.0–8.7) 0.281
cCDCB (%) 1.5 (0.0–16.0) 1.3 (0.0–9.8) 0.459
Length of CD lines, mm 3.5 (2.0–12.0) 3.4 (2.0–8.0) 0.806
Length of CB lines, mm 4.2 (2.0–42.0) 4.0 (2.0–18.0) 0.259
Length of cCDCB lines, mm 13.5 (4.0–77.0) 12.5 (4.0–33.5) 0.315
∆CT, ms 14.5 (12.0–43.0) 13.5 (12.0–36.0) 0.020
P<0.05 statistically significant values. BB indicates Bachmann bundle; CB, conduction block; cCDCB, continuous conduction delay 
conduction block; CD, conduction delay; LA, left atrium; PV, pulmonary veins; and RA, right atrium.
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Figure 4. Bar graphs demonstrating the degree of severity of conduction block (CB).
The y axis represents the relative distribution of ∆CT (%), provided ∆CT ≥12 ms, for obese and nonobese patients separately. The x axis 
represents the median length of conduction time. The P value refers to the difference in median ∆CT between obese and nonobese patients. 
The upper panel shows a significant increase in median ∆CT (ms) in obese compared with nonobese patients. Severity of CB was also higher 
in obese patients particularly in Bachmann bundle (BB) and pulmonary vein (PV) area, as shown in left mid and lower panels, respectively. LA 
indicates left atrium; and RA, right atrium.
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Obesity, Conduction Abnormalities, and EPoAF
Previous studies have demonstrated that BMI, a mea-
sure of overall adiposity, is a strong independent asso-
ciated factor with not only AF but also PoAF.15,25–28 In 
a meta-analysis of the association between obesity and 
postoperative atrial fibrillation in patients without pre-
vious history of AF, Phan et al found that obesity was 
associated with a significant risk of postoperative atrial 
fibrillation. Moreover, Munger et al showed that obesity 
was associated with shorter effective refractory period 
(ERP) in the LA, proximal and distal PV in 63 patients 
with AF undergoing catheter ablation. In our study, we 
found that obese patients had a higher incidence of 
EPoAF. Multivariate analysis showed that a 1.064 unit 
increase in BMI resulted in a higher incidence of EPoAF 
(P=0.037). Previous studies demonstrated that 1-unit 
rise in BMI increases the frequency of newly devel-
oped AF by 4%.18 Comparable to other studies, we also 
found other comorbidities contributing to development of 
EPoAF including incidence of mitral valve disease, hyper-
tension, and left atrial enlargement.29
In our study, the incidence of CB in the entire atria 
independently predicted development of EPoAF. Karaca 
et al30 investigated the value of interatrial conduction 
time for the prediction of EPoAF using intraoperative 
transoesophageal echocardiography and found a signifi-
cant increase in EPoAF in patients with a longer inter-
atrial conduction time. The observation in our study that 
obese patients had overall more conduction abnormali-
ties than nonobese patients and both CB incidence and 
BMI were predictive of EPoAF suggests that obesity-
related heterogeneity in conduction plays an important 
role in development of EPoAF.
Conclusions
Obesity may predispose to a larger incidence, extensive-
ness, and severity of CD and/or CB at the atrial epicar-
dial surface during SR in patients without a history of 
AF. There were more conduction disorders at BB, and 
this area has a higher incidence of CD, CB, and cCDCB 
and longer CD and cCDCB lines. The severity of CB is 
also higher, particularly in the BB and PV areas. However, 
whether obesity alone is responsible for all the electro-
pathological abnormalities remains to be further investi-
gated. To determine the impact of obesity-induced atrial 
conduction abnormalities on long-term clinical outcome, 
further prospective studies are mandatory.
As experimental studies showed that the effect of 
obesity on atrial electropathology is reversible with 
weight control, further studies are needed to evaluate 
whether preventive lifestyle also reverses electropathol-
ogy in humans.
Study Limitations
Recordings of the interatrial septum could not be 
obtained during closed beating heart epicardial mapping 
approach. Due to the invasive mapping approach, healthy 
patients could not be included.
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Table 3. Clinical and Electrophysiological Risk Factors for 
Incidence of EPoAF
Variables OR 95% CI for OR P Value
Univariate analysis
 HT 1.559 1.149–2.115 0.004*
 HL 1.332 0.991–1.792 0.058
 DM 1.126 0.816–1.554 0.471
 LAE 1.908 1.186–3.072 0.008*
 BMI 1.084 1.050–1.120 <0.001*
 AVD 1.321 0.487–2.061 0.219
 AVD+CABG 1.486 0.958–2.304 0.177
 CABG 1.114 0.662–1.217 0.486
 MVD 3.013 1.058–8.581 0.039*
 MVD+CABG 9.159 2.925–28.679 <0.001*
 CD% 1.021 0.953–1.093 0.562
 CB% 1.026 0.973–1.083 0.339
 Continuous CDCB% 1.003 0.960–1.047 0.906
 CD lines 0.975 0.872–1.091 0.661
 CB lines 1.012 0.977–1.048 0.493
 Continuous CDCB lines 1.004 0.989–1.020 0.606
Multivariate analysis
 HT 1.551 0.915–2.627 0.103
 HL 2.921 1.706–5.002 <0.001*
 DM 1.667 0.979–2.838 0.060
 LAE 2.302 1.243–4.261 0.008*
 BMI 1.064 1.004–1.127 0.037*
 MVD 1.110 0.321–3.846 0.869
 MVD+CABG 4.146 0.958–17.938 0.057
 CD% 1.026 0.832–1.264 0.814
 CB% 1.307 1.060–1.613 0.012*
 Continuous CDCB% 0.810 0.663–0.991 0.120
 CD lines 0.872 0.693–1.096 0.239
 CB lines 0.969 0.894–1.050 0.443
 Continuous CDCB lines 1.023 0.984–1.063 0.248
AVD indicates atrial valve disease; BMI, body mass index; CABG, coronary artery 
bypass grafting; CB, conduction block; CD, conduction delay; DM, diabetes mellitus; 
EPoAF, early postoperative atrial fibrillation; HL, hyperlipidemia; HT, hypertension; 
LAE, left atrial enlargement; MVD, mitral valve disease; and OR, odds ratio.
*Statistically significant values (P<0.05).
D
ow
nloaded from
 http://ahajournals.org by on July 16, 2020
Schram-Serban et al Conduction Heterogeneity in Obese Patients
Circ Arrhythm Electrophysiol. 2020;13:e008161. DOI: 10.1161/CIRCEP.119.008161 May 2020 445
Acknowledgments
We kindly thank Drs Oei, Bekkers, van de Woestijne, van Leeuwen, Taverne, Birim, 
Mahtab, Bekker, and van Schaagen for their contribution to this work.
Sources of Funding
This study is supported by funding grants from CVON-AFFIP (CardioVasculair 
Onderzoek Nederland–Hartstchting atrial fibrillation fingerprinting; 914728, to 
Drs de Groot and Brundel), NWO-Vidi (Nederlandse Organisatie voor Weten-
schappelijk Onderzoek; 91717339, to Dr de Groot), Biosense Webster, United 
States (ICD 783454, to Dr de Groot) and Medical Delta (to Dr de Groot BJJMB). 
This research (IIS-331 Phase 2) was conducted with financial support from the 
Investigator-Initiated Study Program of Biosense Webster, Inc.
Disclosures
None.
REFERENCES
 1. Dublin S, French B, Glazer NL, Wiggins KL, Lumley T, Psaty BM, 
Smith NL, Heckbert SR. Risk of new-onset atrial fibrillation in relation to 
body mass index. Arch Intern Med. 2006;166:2322–2328. doi: 10.1001/ 
archinte.166.21.2322
 2. Lin YK, Chen YJ, Chen SA. Potential atrial arrhythmogenicity of adipo-
cytes: implications for the genesis of atrial fibrillation. Med Hypotheses. 
2010;74:1026–1029. doi: 10.1016/j.mehy.2010.01.004
 3. Mahajan R, Nelson A, Pathak RK, Middeldorp ME, Wong CX, Twomey DJ, 
Carbone A, Teo K, Agbaedeng T, Linz D, et al. Electroanatomical remodel-
ing of the atria in obesity: impact of adjacent epicardial fat. JACC Clinical 
Electrophysiology. 2018;4:1529–1540.
 4. Mahajan R, Lau DH, Brooks AG, Shipp NJ, Manavis J, Wood JP, Finnie JW, 
Samuel CS, Royce SG, Twomey DJ, et al. Electrophysiological, electroana-
tomical, and structural remodeling of the atria as consequences of sustained 
obesity. J Am Coll Cardiol. 2015;66:1–11. doi: 10.1016/j.jacc.2015.04.058
 5. Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, Alasady M, Mahajan R, 
Kuklik P, Zhang Y, Brooks AG, et al. Obesity results in progressive atrial 
structural and electrical remodeling: implications for atrial fibrillation. Heart 
Rhythm. 2013;10:90–100. doi: 10.1016/j.hrthm.2012.08.043
 6. Lanters EAH, Yaksh A, Teuwen CP, van der Does LJME, Kik C, Knops P, 
van Marion DMS, Brundel BJJM, Bogers AJJC, Allessie MA, et al. Spa-
tial distribution of conduction disorders during sinus rhythm. Int J Cardiol. 
2017;249:220–225. doi: 10.1016/j.ijcard.2017.08.067
 7. Teuwen CP, Yaksh A, Lanters EA, Kik C, van der Does LJ, Knops P, Taverne 
YJ, van de Woestijne PC, Oei FB, Bekkers JA, et al. Relevance of conduction 
disorders in Bachmann’s bundle during sinus rhythm in humans. Circ Arrhythm 
Electrophysiol. 2016;9:e003972. doi: 10.1161/CIRCEP.115.003972
 8. Teuwen CP, Ramdjan TT, Götte M, Brundel BJ, Evertz R, Vriend JW, 
Molhoek SG, Dorman HG, van Opstal JM, Konings TC, et al. Time course 
of atrial fibrillation in patients with congenital heart defects. Circ Arrhythm 
Electrophysiol. 2015;8:1065–1072. doi: 10.1161/CIRCEP.115.003272
 9. Allessie MA, de Groot NM, Houben RP, Schotten U, Boersma E, 
Smeets JL, Crijns HJ. Electropathological substrate of long-standing per-
sistent atrial fibrillation in patients with structural heart disease: longitudinal 
dissociation. Circ Arrhythm Electrophysiol. 2010;3:606–615. doi: 10.1161/ 
CIRCEP.109.910125
 10. de Groot N, van der Does L, Yaksh A, Lanters E, Teuwen C, Knops P, 
van de Woestijne P, Bekkers J, Kik C, Bogers A, et al. Direct proof of endo-
epicardial asynchrony of the atrial wall during atrial fibrillation in humans. 
Circ Arrhythm Electrophysiol. 2016;9:e003648.
 11. de Groot NM, Houben RP, Smeets JL, Boersma E, Schotten U, 
Schalij MJ, Crijns H, Allessie MA. Electropathological substrate of long-
standing persistent atrial fibrillation in patients with structural heart dis-
ease: epicardial breakthrough. Circulation. 2010;122:1674–1682. doi: 
10.1161/CIRCULATIONAHA.109.910901
 12. Spach MS, Dolber PC, Heidlage JF. Influence of the passive anisotropic 
properties on directional differences in propagation following modification 
of the sodium conductance in human atrial muscle. A model of reentry 
based on anisotropic discontinuous propagation. Circ Res. 1988;62:811–
832. doi: 10.1161/01.res.62.4.811
 13. Tedrow UB, Conen D, Ridker PM, Cook NR, Koplan BA, Manson JE, 
Buring JE, Albert CM. The long- and short-term impact of elevated body mass 
index on the risk of new atrial fibrillation the WHS (women’s health study). J 
Am Coll Cardiol. 2010;55:2319–2327. doi: 10.1016/j.jacc.2010.02.029
 14. Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T, Somers VK. 
Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J 
Am Coll Cardiol. 2007;49:565–571. doi: 10.1016/j.jacc.2006.08.060
 15. Wang TJ, Parise H, Levy D, D’Agostino RB Sr, Wolf PA, Vasan RS, 
Benjamin EJ. Obesity and the risk of new-onset atrial fibrillation. JAMA. 
2004;292:2471–2477. doi: 10.1001/jama.292.20.2471
 16. Sons HU, Hoffmann V. Epicardial fat cell size, fat distribution and fat infil-
tration of the right and left ventricle of the heart. Anatomischer Anzeiger. 
1986;161:355–373.
 17. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Relation 
between epicardial adipose tissue and left ventricular mass. Am J Cardiol. 
2004;94:1084–1087. doi: 10.1016/j.amjcard.2004.06.075
 18. Csige I, Ujvárosy D, Szabó Z, Lőrincz I, Paragh G, Harangi M, 
Somodi S. The impact of obesity on the cardiovascular system. J Diabetes 
Res. 2018;2018:3407306. doi: 10.1155/2018/3407306
 19. Eckstein J, Zeemering S, Linz D, Maesen B, Verheule S, van Hunnik A, 
Crijns H, Allessie MA, Schotten U. Transmural conduction is the predominant 
mechanism of breakthrough during atrial fibrillation: evidence from simulta-
neous endo-epicardial high-density activation mapping. Circ Arrhythm Elec-
trophysiol. 2013;6:334–341. doi: 10.1161/CIRCEP.113.000342
 20. Maesen B, Zeemering S, Afonso C, Eckstein J, Burton RA, van Hunnik A, 
Stuckey DJ, Tyler D, Maessen J, Grau V, et al. Rearrangement of atrial bundle 
architecture and consequent changes in anisotropy of conduction consti-
tute the 3-dimensional substrate for atrial fibrillation. Circ Arrhythm Electro-
physiol. 2013;6:967–975. doi: 10.1161/CIRCEP.113.000050
 21. Zlochiver S, Muñoz V, Vikstrom KL, Taffet SM, Berenfeld O, Jalife J.  
Electrotonic myofibroblast-to-myocyte coupling increases propensity to 
reentrant arrhythmias in two-dimensional cardiac monolayers. Biophys J. 
2008;95:4469–4480. doi: 10.1529/biophysj.108.136473
 22. Magnani JW, Lopez FL, Soliman EZ, Maclehose RF, Crow RS, Alonso A. 
P wave indices, obesity, and the metabolic syndrome: the atherosclerosis 
risk in communities study. Obesity (Silver Spring). 2012;20:666–672. doi: 
10.1038/oby.2011.53
 23. Saremi F, Torrone M, Yashar N. Cardiac conduction system: delineation of 
anatomic landmarks with multidetector CT. Indian Pacing Electrophysiol J. 
2009;9:318–333.
 24. Friedman DJ, Wang N, Meigs JB, Hoffmann U, Massaro JM, Fox CS, Magnani JW. 
Pericardial fat is associated with atrial conduction: the Framingham Heart 
Study. J Am Heart Assoc. 2014;3:e000477. doi: 10.1161/JAHA.113.000477
 25. Esato M, Shimizu A, Chun YH, Tatsuno H, Yamagata T, Matsuzaki M. Elec-
trophysiologic effects of a class I antiarrhythmic agent, cibenzoline, on the 
refractoriness and conduction of the human atrium in vivo. J Cardiovasc Phar-
macol. 1996;28:321–327. doi: 10.1097/00005344-199608000-00020
 26. Phan K, Khuong JN, Xu J, Kanagaratnam A, Yan TD. Obesity and post-
operative atrial fibrillation in patients undergoing cardiac surgery: Sys-
tematic review and meta-analysis. Int J Cardiol. 2016;217:49–57. doi: 
10.1016/j.ijcard.2016.05.002
 27. Serban C, Arinze JT, Starreveld R, Lanters EAH, Yaksh A, Kik C, Acardag Y, 
Knops P, Bogers AJJC, de Groot NMS. The impact of obesity on early post-
operative atrial fibrillation burden. J Thorac Cardiovasc Surg. 2020;159:930–
938.e2. doi: 10.1016/j.jtcvs.2019.03.073
 28. Munger TM, Dong YX, Masaki M, Oh JK, Mankad SV, Borlaug  
BA, Asirvatham SJ, Shen WK, Lee HC, Bielinski SJ, et al. Electrophysi-
ological and hemodynamic characteristics associated with obesity in 
patients with atrial fibrillation. J Am Coll Cardiol. 2012;60:851–860. doi: 
10.1016/j.jacc.2012.03.042
 29. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, 
Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, et al; ESC Com-
mittee for Practice Guidelines. Guidelines for the management of atrial 
fibrillation: the Task Force for the Management of Atrial Fibrillation of the 
European Society of Cardiology (ESC). Europace. 2010;12:1360–1420. 
doi: 10.1093/europace/euq350
 30. Karaca M, Demirbas MI, Biceroglu S, Cevik A, Cetin Y, Arpaz M, Yilmaz H. 
Prediction of early postoperative atrial fibrillation after cardiac surgery: is it 
possible? Cardiovasc J Afr. 2012;23:34–36. doi: 10.5830/CVJA-2011-010
D
ow
nloaded from
 http://ahajournals.org by on July 16, 2020
